ArticleJournal of thrombosis and thrombolysis2021
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients.
Massimo Mattioli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled itcites it